FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107088260> ?p ?o ?g. }

• W2107088260 endingPage "662" @default.
• W2107088260 startingPage "650" @default.
• W2107088260 abstract "Abstract Multidrug resistance observed in cancer chemotherapy is commonly attributed to overexpression of efflux transporter proteins. These proteins act as ATP‐dependent drug efflux pumps, actively extruding chemotherapeutic agents from cells and causing a decrease in intracellular drug accumulation. Besides the well‐recognized role of P‐glycoprotein (P‐gp, ABCB1), the breast cancer resistance protein (BCRP, ABCG2) is becoming increasingly accepted as playing an important role in multidrug resistance. In contrast to P‐glycoprotein, only a few inhibitors of ABCG2 are known. According to the literature, tyrosine kinase inhibitors (TKIs) can be considered to be broad‐spectrum inhibitors, interacting with ABCB1, ABCC1 and ABCG2. Here, we investigated seven different TKIs, gefitinib, erlotinib, AG1478, PD158780, PD153035, nilotinib and imatinib, for their potential to restore ABCG2 sensitivity to cells. Furthermore, we analyzed the alteration of ABCG2 expression caused by TKIs and demonstrated that EGFR inhibitors such as gefitinib and PD158780 reduced both total and surface expression of ABCG2 in EGRF‐positive MDCK BCRP cells by interaction with the PI3K/Akt signaling pathway. The reduced ABCG2 content led to an increased effect of XR9577, a well‐known ABCG2 modulator, lowering the concentration required for half maximal inhibition. On the other hand, BCR‐ABL inhibitors had no influence on ABCG2 expression and modulator activity. Interestingly, a combination of an EGFR inhibitor with the PI3K/Akt inhibitor LY294002 led to a significant reduction of ABCG2 expression at low concentrations of the drugs. Based on our results, we assume that EGFR exerts a post‐transcriptional enhancing effect on ABCG2 expression via the PI3K/Akt signaling pathway, which can be attenuated by EGFR inhibitors. Blocking the key signaling pathway regulating ABCG2 expression with EGFR inhibitors, combined with the inhibition of ABCG2 with potent modulators might be a promising approach to circumvent MDR in cancer cells." @default.
• W2107088260 created "2016-06-24" @default.
• W2107088260 creator A5002055826 @default.
• W2107088260 creator A5052330076 @default.
• W2107088260 date "2012-02-22" @default.
• W2107088260 modified "2023-10-16" @default.
• W2107088260 title "Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway" @default.
• W2107088260 cites W1483167997 @default.
• W2107088260 cites W1557061959 @default.
• W2107088260 cites W1561593600 @default.
• W2107088260 cites W1966159750 @default.
• W2107088260 cites W1973075736 @default.
• W2107088260 cites W1973844537 @default.
• W2107088260 cites W1984246155 @default.
• W2107088260 cites W1986180977 @default.
• W2107088260 cites W1988348505 @default.
• W2107088260 cites W1989064705 @default.
• W2107088260 cites W1993301860 @default.
• W2107088260 cites W1996443605 @default.
• W2107088260 cites W1998428612 @default.
• W2107088260 cites W1999004536 @default.
• W2107088260 cites W2004411620 @default.
• W2107088260 cites W2008790922 @default.
• W2107088260 cites W2018301172 @default.
• W2107088260 cites W2018950591 @default.
• W2107088260 cites W2019346113 @default.
• W2107088260 cites W2020441233 @default.
• W2107088260 cites W2023146604 @default.
• W2107088260 cites W2031564220 @default.
• W2107088260 cites W2036926586 @default.
• W2107088260 cites W2040628852 @default.
• W2107088260 cites W2050767064 @default.
• W2107088260 cites W2051727820 @default.
• W2107088260 cites W2055704714 @default.
• W2107088260 cites W2055903396 @default.
• W2107088260 cites W2057458801 @default.
• W2107088260 cites W2067684482 @default.
• W2107088260 cites W2069382823 @default.
• W2107088260 cites W2071040849 @default.
• W2107088260 cites W2072517578 @default.
• W2107088260 cites W2076174476 @default.
• W2107088260 cites W2077083084 @default.
• W2107088260 cites W2078253401 @default.
• W2107088260 cites W2081710455 @default.
• W2107088260 cites W2083698338 @default.
• W2107088260 cites W2084186083 @default.
• W2107088260 cites W2086399030 @default.
• W2107088260 cites W2094449657 @default.
• W2107088260 cites W2097153541 @default.
• W2107088260 cites W2098064809 @default.
• W2107088260 cites W2102610315 @default.
• W2107088260 cites W2104409728 @default.
• W2107088260 cites W2104711019 @default.
• W2107088260 cites W2109242805 @default.
• W2107088260 cites W2110012018 @default.
• W2107088260 cites W2118207487 @default.
• W2107088260 cites W2118234018 @default.
• W2107088260 cites W2118621423 @default.
• W2107088260 cites W2126376257 @default.
• W2107088260 cites W2147445587 @default.
• W2107088260 cites W2148917087 @default.
• W2107088260 cites W2153241046 @default.
• W2107088260 cites W2156609950 @default.
• W2107088260 cites W2157277269 @default.
• W2107088260 cites W2159398836 @default.
• W2107088260 cites W2159854260 @default.
• W2107088260 cites W2161632561 @default.
• W2107088260 cites W2169120362 @default.
• W2107088260 cites W2188149910 @default.
• W2107088260 cites W2322071938 @default.
• W2107088260 doi "https://doi.org/10.1002/cmdc.201100543" @default.
• W2107088260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22354538" @default.
• W2107088260 hasPublicationYear "2012" @default.
• W2107088260 type Work @default.
• W2107088260 sameAs 2107088260 @default.
• W2107088260 citedByCount "73" @default.
• W2107088260 countsByYear W21070882602012 @default.
• W2107088260 countsByYear W21070882602013 @default.
• W2107088260 countsByYear W21070882602014 @default.
• W2107088260 countsByYear W21070882602015 @default.
• W2107088260 countsByYear W21070882602016 @default.
• W2107088260 countsByYear W21070882602017 @default.
• W2107088260 countsByYear W21070882602018 @default.
• W2107088260 countsByYear W21070882602019 @default.
• W2107088260 countsByYear W21070882602020 @default.
• W2107088260 countsByYear W21070882602021 @default.
• W2107088260 countsByYear W21070882602022 @default.
• W2107088260 countsByYear W21070882602023 @default.
• W2107088260 crossrefType "journal-article" @default.
• W2107088260 hasAuthorship W2107088260A5002055826 @default.
• W2107088260 hasAuthorship W2107088260A5052330076 @default.
• W2107088260 hasConcept C104317684 @default.
• W2107088260 hasConcept C121608353 @default.
• W2107088260 hasConcept C133936738 @default.
• W2107088260 hasConcept C149011108 @default.
• W2107088260 hasConcept C170493617 @default.
• W2107088260 hasConcept C185592680 @default.
• W2107088260 hasConcept C2776912716 @default.

• next